| abstract |
The present invention relates to novel pharmaceutical uses of compounds which act as inhibitors of nitric oxide synthase (NOS). Specifically, these inhibitors of NOS, in particular selective neuronal NOS (N-NOS) inhibitors: (a) alone or in combination with another active agent in the treatment of psoriasis; (b) a narcotic analgesic (e.g., morphine or opiates such as demerol); (d) alone or in combination with other active ingredients for the development of perception; and (e) alone or in combination with other active agents for the treatment of sleep disorders such as apenea, narcolepsy and insomnia. |